Search Results

There are 52938 results for: content related to: Nebivolol in Obese and Non-Obese Hypertensive Patients

  1. You have free access to this content
    Investigation of the different adrenoceptor targets of nebivolol enantiomers in rat thoracic aorta

    British Journal of Pharmacology

    Volume 156, Issue 4, February 2009, Pages: 601–608, T Tran Quang, B Rozec, L Audigane and C Gauthier

    Version of Record online : 4 FEB 2009, DOI: 10.1111/j.1476-5381.2009.00074.x

  2. Nebivolol: Pharmacologic Profile of an Ultraselective, Vasodilatory β1-Blocker

    The Journal of Clinical Pharmacology

    Volume 48, Issue 2, February 2008, Pages: 225–239, L. Michael Prisant

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270007310378

  3. You have free access to this content
    A Randomized, Double-Blind, Placebo-Controlled Parallel-Group Study to Assess the Efficacy and Safety of Nebivolol, a Novel β-Blocker, in Patients With Mild to Moderate Hypertension

    The Journal of Clinical Hypertension

    Volume 9, Issue 9, September 2007, Pages: 667–676, Robert J. Weiss, Michael A. Weber, Albert A. Carr and Will A. Sullivan

    Version of Record online : 5 SEP 2007, DOI: 10.1111/j.1524-6175.2007.06679.x

  4. Effects of Commonly Administered Agents and Genetics on Nebivolol Pharmacokinetics: Drug-Drug Interaction Studies

    The Journal of Clinical Pharmacology

    Volume 51, Issue 4, April 2011, Pages: 575–585, Dr Charles Lindamood, Dr Stephan Ortiz, Dr Andrew Shaw, Dr Russ Rackley and Dr J. Christopher Gorski

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010370846

  5. You have free access to this content
    Different Pharmacological Properties of Two Enantiomers in a Unique β-Blocker, Nebivolol

    Cardiovascular Therapeutics

    Volume 26, Issue 2, Summer 2008, Pages: 115–134, Louis J. Ignarro

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1527-3466.2008.00044.x

  6. You have free access to this content
    Nebivolol: A Highly Selective β1-Adrenergic Receptor Blocker That Causes Vasodilation by Increasing Nitric Oxide

    Cardiovascular Therapeutics

    Volume 26, Issue 3, Fall 2008, Pages: 189–202, Sandeep Gupta and Harold M. Wright

    Version of Record online : 13 AUG 2008, DOI: 10.1111/j.1755-5922.2008.00054.x

  7. Nebivolol Dilates Human Penile Arteries and Reverses Erectile Dysfunction in Diabetic Rats through Enhancement of Nitric Oxide Signaling

    The Journal of Sexual Medicine

    Volume 7, Issue 8, August 2010, Pages: 2681–2697, Javier Angulo, Harold M. Wright, Pedro Cuevas, Rocío González-Corrochano, Argentina Fernández, Begoña Cuevas, José M. La Fuente, Sandeep Gupta and Iñigo Sáenz de Tejada

    Version of Record online : 26 FEB 2010, DOI: 10.1111/j.1743-6109.2010.01710.x

  8. Effect of nebivolol on renal nitric oxide availability and tubular function in patients with essential hypertension

    British Journal of Clinical Pharmacology

    Volume 80, Issue 3, September 2015, Pages: 425–435, Frank H. Mose, Janni M. Jensen, Safa Therwani, Jesper Mortensen, Annebirthe B. Hansen, Jesper N. Bech and Erling B. Pedersen

    Version of Record online : 5 JUN 2015, DOI: 10.1111/bcp.12627

  9. You have free access to this content
    Pharmacological Mechanisms of Clinically Favorable Properties of a Selective β1-Adrenoceptor Antagonist, Nebivolol

    Cardiovascular Drug Reviews

    Volume 22, Issue 3, September 2004, Pages: 155–168, Alexey Kuroedov, Francesco Cosentino and Thomas F. Lüscher

    Version of Record online : 7 JUN 2006, DOI: 10.1111/j.1527-3466.2004.tb00138.x

  10. A pharmacokinetic drug interaction study between nebivolol and paroxetine in healthy volunteers

    Journal of Clinical Pharmacy and Therapeutics

    Volume 39, Issue 5, October 2014, Pages: 535–540, C. Briciu, M. Neag, D. Muntean, L. Vlase, C. Bocsan, A. Buzoianu, A.-M. Gheldiu, M. Achim and A. Popa

    Version of Record online : 21 MAY 2014, DOI: 10.1111/jcpt.12180

  11. You have free access to this content
    Effects of the long-term administration of nebivolol on the clinical symptoms, exercise capacity, and left ventricular function of patients with diastolic dysfunction: results of the ELANDD study

    European Journal of Heart Failure

    Volume 14, Issue 2, February 2012, Pages: 219–225, Viviane M. Conraads, Marco Metra, Otto Kamp, Gilles W. De Keulenaer, Burkert Pieske, José Zamorano, Panos E. Vardas, Michael Böhm and Livio Dei Cas

    Version of Record online : 18 FEB 2014, DOI: 10.1093/eurjhf/hfr161

  12. Cardiovascular Effects of Intracerebroventricular Injections of (±)-Nebivolol and its Enantiomers—a Comparison with those of Metoprolol in the Rat

    Journal of Pharmacy and Pharmacology

    Volume 43, Issue 7, July 1991, Pages: 504–509, M. MIDOL-MONNET, M. DAVY, M. HEIMBURGER, F. BESLOT and Y. COHEN

    Version of Record online : 12 APR 2011, DOI: 10.1111/j.2042-7158.1991.tb03523.x

  13. You have free access to this content
    Nebivolol Efficacy and Safety in Patients with Stage I-II Hypertension

    Clinical Cardiology

    Volume 33, Issue 4, April 2010, Pages: E20–E27, Mark Greathouse

    Version of Record online : 16 FEB 2010, DOI: 10.1002/clc.20508

  14. Nebivolol Potentiates the Efficacy of PDE5 Inhibitors to Relax Corpus Cavernosum and Penile Arteries from Diabetic Patients by Enhancing the NO/cGMP Pathway

    The Journal of Sexual Medicine

    Volume 11, Issue 5, May 2014, Pages: 1182–1192, Juan I. Martínez-Salamanca, José M. La Fuente, José Cardoso, Argentina Fernández, Pedro Cuevas, Harold M. Wright and Javier Angulo

    Version of Record online : 20 FEB 2014, DOI: 10.1111/jsm.12477

  15. You have free access to this content
    Effects of Add-On Nebivolol on Blood Pressure and Glucose Parameters in Hypertensive Patients With Prediabetes

    The Journal of Clinical Hypertension

    Volume 15, Issue 4, April 2013, Pages: 270–278, Prakash Deedwania, John Shea, Wei Chen and Lillian Brener

    Version of Record online : 1 FEB 2013, DOI: 10.1111/jch.12071

  16. Beta-blockade with nebivolol enhances the acetylcholine-induced cutaneous vasodilation

    Clinical Pharmacology & Therapeutics

    Volume 69, Issue 4, April 2001, Pages: 238–244, Sandrine Kubli, François Feihl and Bernard Waeber

    Version of Record online : 2 APR 2001, DOI: 10.1067/mcp.2001.114670

  17. You have free access to this content
    The influence of CYP2D6 phenotype on the clinical response of nebivolol in patients with essential hypertension

    British Journal of Clinical Pharmacology

    Volume 63, Issue 5, May 2007, Pages: 575–582, Jean Lefebvre, Luc Poirier, Paul Poirier, Jacques Turgeon and Yves Lacourciere

    Version of Record online : 10 NOV 2006, DOI: 10.1111/j.1365-2125.2006.02796.x

  18. Influence of chronic kidney disease and haemodialysis treatment on pharmacokinetics of nebivolol enantiomers

    British Journal of Clinical Pharmacology

    Volume 82, Issue 1, July 2016, Pages: 83–91, Daniel V. Neves, Vera L. Lanchote, Miguel Moysés Neto, José A. Cardeal da Costa, Carolina P. Vieira and Eduardo B. Coelho

    Version of Record online : 7 APR 2016, DOI: 10.1111/bcp.12917

  19. You have free access to this content
    Blood Pressure Effects of Combined β-Blocker and Angiotensin-Converting Enzyme Inhibitor Therapy Compared With the Individual Agents: A Placebo-Controlled Study With Nebivolol and Lisinopril

    The Journal of Clinical Hypertension

    Volume 14, Issue 9, September 2012, Pages: 588–592, Michael A. Weber, Jan Basile, Manfred Stapff, Barbara Khan and Dongli Zhou

    Version of Record online : 4 JUN 2012, DOI: 10.1111/j.1751-7176.2012.00666.x

  20. You have free access to this content
    The Efficacy and Tolerability of Nebivolol in Hypertensive African American Patients

    The Journal of Clinical Hypertension

    Volume 9, Issue 11, November 2007, Pages: 866–875, Elijah Saunders, 1 William B. Smith, 2 Karen B. DeSalvo and 3 Will A. Sullivan 4

    Version of Record online : 16 NOV 2007, DOI: 10.1111/j.1524-6175.2007.07548.x